ctrl K

Watchlist Price Alert

LAVA Therapeutics N.V. (LVTX)

NASDAQ: LVTX · Real-Time Price · USD

1.27

0.00 (0.00%)

At close: May 09, 2025, 3:59 PM

1.24

-2.36%

After-hours: May 09, 2025, 04:05 PM EDT

LAVA Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	11.98M	6.77M	19.39M	5.35M	3.75M	n/a
Cost of Revenue	467K	3.48M	n/a	n/a	15.7M	8.35M
Gross Profit	11.52M	3.29M	19.39M	5.35M	-11.95M	-8.35M
Operating Income	-29.69M	-43.25M	-34.84M	-43.61M	-14.67M	-9.58M
Interest Income	3.76M	2.97M	257K	625K	342K	86K
Pretax Income	-24.48M	-41.7M	-31.66M	-42.2M	-15.88M	-9.69M
Net Income	-25.11M	-41.97M	-31.91M	-42.35M	-15.93M	-9.69M
Selling & General & Admin	13.22M	12.73M	14.12M	12.02M	2.72M	1.24M
Research & Development	28.45M	33.81M	40.1M	36.95M	15.7M	8.35M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	41.67M	46.54M	51.31M	46.92M	3.59M	1.25M
Interest Expense	515K	n/a	n/a	625K	342K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	41.67M	50.02M	51.31M	46.92M	19.29M	9.6M
Income Tax Expense	630K	279K	249K	157K	43K	n/a
Shares Outstanding (Basic)	26.83M	26.73M	25.92M	19.76M	25.35M	18.41M
Shares Outstanding (Diluted)	26.83M	26.73M	25.92M	19.76M	25.35M	18.41M
EPS (Basic)	-0.94	-1.57	-1.23	-2.14	-39.9	-21.65
EPS (Diluted)	-0.94	-1.57	-1.23	-2.14	-39.9	-21.65
EBITDA	-23.5M	-40.42M	-30.88M	-41.02M	-14.65M	-9.48M
EBIT	-23.97M	-41.46M	-31.58M	-41.57M	-15.11M	-9.62M
Depreciation & Amortization	467K	1.28M	504K	331K	213K	99K